Subscribe to our Newsletters !!

    Natural

    BD Announces Assay for Identification of COVID-19 Patients

    EYSINS, Switzerland, February 03, 2021/BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the CE mark of BD Multitest™ 6-Color TBNK Reagent with BD Trucount™ Tubes with expanded clinical application to help clinicians identify COVID-19 patients at increased relative risk of intubation with mechanical ventilation (IMV) and mortality at